Thanks, stuffit, for inviting me to participate! I certainly didn't expect to win when one of my two picks had a negative return during the 2-month period.
ENTA is indeed a very good biotech stock, IMO. It's my largest holding, and I haven't sold any shares since initialing a position in mid 2013 (#msg-89490439) and adding to it in Jan 2014 when two insiders sent a bullish signal (#msg-95923408). Regards, Dew
p.s. For readers who are interested in learning more about ENTA, here are two posts to start your DD: #msg-94993406 (valuation model) and #msg-96696670 (phase-3 clinical data). There's a lot of discussion about ENTA on the Biotech Values board at #board-1418.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”